Get quotes from 3 top Symptomatic treatment surgeons

Education:  Azerbaijan Medical University, Pediatrics, 2003-2009, Pediatrician  Ministry of Justice of the Republic of Azerbaijan, Intern, 2009-2010, Anesthesiologistreanimatologist (Intensive Therapy) Work experience:  Liv Bona Dea International Hospital, Emergency Physician June 2019 – present  International SOS (GIM) / BP AGT Caspian Sea "Shah Deniz Bravo" Project, Azerbaijan, Caspian Sea, Field doctor February 2017-November 2019  Azerbaijan National Anti-Doping Agency (AMADA), Azerbaijan, Baku, Doping Control Inspector June 2017  4th Islamic Solidarity Games, Azerbaijan, Baku, Medical consultant of Heydar Aliyev arena, May 2017  International SOS (GIM) / BP AGT Caspian Sea “Deepwater Gunashli” Project, Azerbaijan, Caspian Sea, Field Doctor January 2015 – January 2017  International SOS (GIM), Azerbaijan, Baku, site coordinator April 2014-December 2014  Doctor at the Central Neftchilar Hospital, Baku, Azerbaijan, Reanimation and Intensive Therapy Department (trial period) April-September 2012  Premium Assist Insurance Company, Azerbaijan, Baku, Chief Medical Expert (Night shift) AprilSeptember 2012  Medical intern at the Department of Anesthesiology and Intensive Therapy in various institutions under the Ministry of Justice of the Republic of Azerbaijan, Baku, Azerbaijan, August 2009- July 2010  Medi Club Clinic, Azerbaijan, Baku, Physician Assistant/Emergency paramedic August 2007 – July 2010 

Areas of activity: • Research of pathology in gerontological age group (elderly) patients • Clinical nutrition (enteral and parenteral nutrition) • Diabetes mellitus, metabolic syndrome, osteoporosis, thyroid diseases • Arterial hypertension • High body temperature of unknown genesis (fever) • Diseases of the musculoskeletal system, rheumatological diseases • Diseases of the gastrointestinal tract, liver • Disorders of water and electrolyte metabolism, kidney diseases Education: • Higher education - Azerbaijan Medical University, Faculty of General Medicine and Prevention, 2008-2014 • Specialization – Istanbul University, Istanbul Faculty of Medicine, Department of Internal Medicine Work experience: • Baku State Hospital No. 3, resident physician nephrologist. 2014-2016 • Istanbul Private Bahcelievler Memorial Hospital, specialist in internal medicine. 2021-2022 Research work: (dissertation / defense) • Clinical and laboratory features of patients with acute interstitial nephritis diagnosed during kidney biopsy, factors influencing the etiology and response to treatment. Istanbul University, Istanbul Faculty of Medicine, Department of Nephrology, 2021 Publications:(2) •P343Efficacy of adalimumab mild-to-moderate inflammatory bowel disease: Real-life data from a single-centre experience in the long-term period. January 2020 Journal of Crohns and Colitis DOI: 10.1093/ecco-jcc/jjz203.472 •Concurrent myelomatous pleural effusion and extramedullary mediastinalinvolvement as a relapse manifestation of multiple myeloma. Abstract of the IXth International Eurasian Hematology OncologyCongress17–20October2018Istanbul,Turkey(Concomitant myelomatous pleurisy and extramedullary mediastinal lesion as a recurrent manifestation of multiple myeloma. Abstracts of the IX International Eurasian Oncohematology Congress17–20October2018Istanbul,Türkiye) Memberships in scientific organizations: •Turkish Medical Association

Dr. Victor Alexander Krol - Chief of Gastroenterology, Internal Medicine and Obesity Treatment Center at Martinus Hospital

Dr. Victor Alexander Krol is a highly qualified specialist, heading the departments of gastroenterology and internal medicine. With many years of experience and deep knowledge in his field, Dr. Krol has established himself as an outstanding expert, providing patients with comprehensive treatment and an individual approach. He actively uses the latest methods of diagnosis and treatment of diseases of the gastrointestinal tract, metabolism, as well as diseases of the cardiovascular and respiratory systems.

Dr. Krol is also the director of the certified Obesity Treatment Center at Martinus Hospital, which provides surgical and endoscopic treatments for obesity. The center uses advanced technology to diagnose and treat obesity (adiposis), including methods such as bariatric surgery, endoscopic weight loss, and specialized programs for patients with different stages of obesity. The center is certified to high standards and has excellent results in the treatment of this serious disease.

The Gastroenterology Department, headed by Dr. Krol, diagnoses and treats diseases of the stomach, intestines, liver, pancreas, and gallbladder. The doctors of the department use a wide range of methods, including endoscopic procedures, ultrasound, and other modern diagnostic technologies.

The Department of Internal Medicine covers a wide range of diseases, including cardiology, diabetology, infectology, and therapy of respiratory and renal diseases. Dr. Krol and his team provide a comprehensive approach to treatment using the most advanced methods of medicine.

Thanks to his high professionalism and humane approach to each patient, Dr. Krol deservedly enjoys the respect of colleagues and patients.

Dr. Marc Ulrich Becher is an interventional cardiologist and heart failure specialist at Städtisches Klinikum Solingen. He is known for performing advanced procedures such as coronary angiography, radiofrequency ablation with 3D mapping, carotid angioplasty, and stenting.

Dr. Becher’s clinic carries out about 3,000 to 4,000 diagnostic and therapeutic procedures each year. These include complex coronary interventions, catheter-based valve replacements, and structural heart procedures. He is experienced in using advanced imaging techniques like IVUS and OCT for accurate diagnosis and treatment planning.

Dr. Becher is dedicated to providing thorough and compassionate care. He uses modern therapies for both acute and chronic cardiovascular diseases, focusing on patient safety and positive outcomes.

Professor Markus Dukes is a specialist in diagnostic radiology and minimally invasive therapy.

Awards

• Gold Medal of Honorary Professor of Osaka Medical University (Japan).
• Honorary member of DeGIR (German Society for Interventional Radiology and Minimally Invasive Therapy).

Education and professional experience

• 1982-1988 - study of human medicine at the Johannes-Gutenberg University in Mainz.
• 1988 - approval and medical license.
• 1988-1989 - Medical officer of the Bundeswehr.
• 1990 - Candidate of Medical Sciences in the field of radiology, subject: “Investigation of the influence of dilation speed on its success, as well as on damage to the vessel walls during balloon expansion”, at the Johannes-Gutenberg University in Mainz.
• 1990-1996 - Resident in the Department of Radiology at the Ruprecht-Karls University.
• 1996 - Senior physician in the Department of Radiodiagnostics at the Ruprecht-Karls University of Heidelberg.
• 1998 - Doctorate in Diagnostic Radiology, topic: "Direct comparison of imaging methods for gastric carcinoma: the importance of optimized examination methods in clinical practice and first experience with magnetic resonance imaging."
• 2000 - Deputy Head of the Department of Radiology, Department of Radiodiagnostics at the Ruprecht-Karls University of Heidelberg.
• 2000-2002 - Head of the Image Processing Center at the Orthopedic Clinic of the University of Heidelberg.
• 2002-2003 - Head of the Department of Radiology, Surgical Clinic, Department of Radiology at the Ruprecht-Karls University of Heidelberg.
• 2003 - Chief Physician of the Central Institute of Radiology and Neuroradiology at the Nordwest Clinic in Frankfurt am Main.
• 2006 - Associate Professor in the Department of Radiology at the University of Heidelberg.

Scientific activity

Marcus Dukes is one of the first physicians to perform minimally invasive microwave ablation of liver and lung tumors under CT guidance.

Clinical activities

The professor heads the first and only MRI-guided FUS ablation center in the Rhine-Main region. In most cases, the procedure allows avoiding surgical intervention. Patients of the center have access to ablation for prostate cancer, bone and liver metastases, benign tumors, and treatment of uterine fibroids without surgery.

Membership in organizations

• DRG (German Society of Radiologists).
• DeGIR (German Society for Interventional Radiology and Minimally Invasive Therapy).
• RSNA (Radiological Society of North America).
• ESGAR (European Society of Gastrointestinal and Abdominal Radiology).
• CIRSE (Cardiovascular and Interventional Radiology Society of Europe).
• ECR (European Congress of Radiology).
• EUFUS (European FUS Society).
• MEDICA (German Society for Interdisciplinary Medicine).

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

• Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
• Role: Subinvestigator

2. PFİZER

• Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
• Role: Subinvestigator

3. RECITE - AMGEN

• Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
• Role: Subinvestigator

4. NAVIGATE - BAYER

• Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
• Role: Subinvestigator

5. RUBY - Tesaro (PRA)

• Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
• Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

• Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
• Role: Subinvestigator

7. ASTRA ZENECA

• Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
• Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

• Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
• Role: Subinvestigator
•  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
• Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
• Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

• Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
• Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

• Authors: Paksoy, Nail, et al.
• Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

• Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
• Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

• Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
• Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

• Authors: HAS SIMSEK, Duygu, et al.
• Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

• Authors: FERHATOGLU, Ferhat, et al.
• Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

• Authors: GÜRBÜZ, Mustafa, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

• Authors: AY, Seval, et al.
• Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

• Authors: CIL, Ibrahim, et al.
• Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

• Authors: HIZAL, Mutlu, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
• Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
• Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

• Authors: DEMIR, Semra, et al.
• Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

• Authors: ÖZDEMIR, Seçil Kepil, et al.
• Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

• Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
• Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

• Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
• Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
• Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
• Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

• Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
• Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

• Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
• Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

• Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
• Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

• Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
• Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

• Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
• Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

• Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

• Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

• Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

• Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

• Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

• Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

• Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

• Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

Experience

2018 - 2022

Health Sciences University – Şişli Hamidiye Etfal Training and Research Hospital

2016 - 2018

Diyarbakır Memorial Dicle Hospital Cardiology Clinic

2010 - 2010

Dicle University Faculty of Medicine, Department of Cardiology

2010 - 2016

Private Veni Vidi Hospital, Cardiology Clinic Supervisor

2006 - 2010

Dicle University Faculty of Medicine, Department of Cardiology

2005 - 2006

Urfa State Hospital

1999 - 2005

Turkey High Specialization Training and Research Hospital

1998 - 1999

Duruca Health Center

Education

2018

Health Sciences University, Cardiology

2010

Dicle University, Department of Cardiology

2005

Cardiology Turkey High Specialization Training and Research Hospital, Medical Specialization

1998

Ege University, Faculty of Medicine

Dr. Sirinda “Ning” Kittiprachakul is a board-certified physiatrist (Thai Board of Rehabilitation Medicine, 2025) at King Chulalongkorn Memorial Hospital. She focuses on neurorehabilitation and cardiac rehabilitation. Her expertise includes geriatric rehabilitation, chronic pain management using Western dry needling, and electrodiagnostic and electromyographic studies.

She earned her MD with First Class Honors in 2020 and completed her Rehabilitation Medicine residency in 2025. She is a Ph.D. candidate in Clinical Sciences at Chulalongkorn University. Her research includes authorship in JACC (2019) and an abstract in Gut (IDDF 2025). She trained at KNRC in Korea in 2024. She received the MDCU Congress 2023 E‑poster consolation prize. She also completed training in HMS telemedicine, Nature Masterclasses, and focused shockwave therapy.

Rawipa Khunnarong, M.D. (Dr. Praew), is a physiatrist at Police General Hospital, Bangkok (2025–present). She provides rehabilitation for musculoskeletal pain, neurological disorders, and functional impairments. She works with multidisciplinary teams and teaches and supervises residents.

Education: M.D., Rangsit University/Rajavithi Hospital (2019). Rehabilitation Medicine Residency, Phramongkutklao College of Medicine (2025). Core expertise includes pain and interventional rehabilitation, neurorehabilitation (stroke, spinal cord injury), dysphagia, and sports and exercise medicine.

Advanced training includes Sports Rehabilitation Beyond Strength (2025), PMK Dry Needling (2025), and the 3rd Musculoskeletal Intervention Course (2025). She also completed a BASEM study visit (2024), Olympus FEES for dysphagia (2024), AOCNR (2023), TRMA (2022), and Viatris programs (2022–2023).

Patthama Likitwittaya, M.D., physiatrist. Diplomate, Thai Board of Rehabilitation Medicine (2025). Rehabilitation Medicine Residency, Faculty of Medicine, Chulalongkorn University (2025). Doctor of Medicine, First-Class Honors, Thammasat University (2019).

Current role: Department of Rehabilitation Medicine, Somdech Phra Pinklao Hospital (July 2025–present). Prior internships: Queen Sirikit Naval Hospital (2019–2020). Songkhla Naval Base Hospital (2020–2021). Naval Hospital Bangkok (2021–2022).

Research: Principal investigator of “Effect of vibrotactile stimulation on gait in Parkinson’s disease and parkinsonism.” Presented at the Royal College of Physiatrists of Thailand (2025).

Advanced training: 29th TOPF Osteoporosis and Related Diseases Grand Round (Dec 2024). Pain management with Focus Shock Wave Piezo Technology (Jul 2024). 35th TASP Annual Scientific Meeting (Mar 2024). Academic and Midyear Conferences of the Royal College of Physiatrists of Thailand (2022). Good Clinical Practice and human subject protection training (Jun 2022).

Dr. Ornicha Thititagul (Dr. Faangkaow) is a geriatrician and lecturer in the Geriatric Medicine Division at Siriraj Hospital, Mahidol University. She practices at Siriraj Samut Sakhon Geriatric Healthcare Center and Siriraj Piyamaharajkarun Hospital.

Accreditations include: M.D. (Second Class Honors, 2017); Diplomate, Thai Board of Internal Medicine (2021); WHO‑SEARO ICOPE Master Trainer (2021). Additional credentials: Diplomate in Geriatric Medicine (2023); Diplomate, International Board of Lifestyle Medicine (2024).

Research highlights include: a randomized controlled trial on oral nutritional supplements in older adults (Geriatrics, 2024); PG‑SGA versus MNA in hepatocellular carcinoma (Support Care Cancer 33, 116, 2025); and Thailand’s first abacavir hypersensitivity case report (J Med Assoc Thai, 2021). She was on the host team and served as a moderator at the 10th Asian Conference of Frailty and Sarcopenia in 2024.

An expert in microbial resistance and optimisation of the use of antimicrobials, he leads the Infectious Disease Unit of this hospital in Malaga.

Dr Javier Moreno Izarra is habitually involved in national and international scientific events. At the same time, he gives presentations that are specially focused on infectious disease in the area of antimicrobial resistance and in medical forums dedicated to the development of programs to optimise the use of antimicrobials.

Professional Experience:

• Head of the Internal Medicine Unit. Quirónsalud Marbella Hospital

• Head of the Internal Medicine Unit. Quirón Campo de Gibraltar Hospital

• Specialist of the Internal Medicine Unit. Alto Guadalquivir Hospital

• Specialist of the Internal Medicine Unit. Andújar Hospital

• Medical Coordination of the A&E Unit and Hospitalisation. High- resolution Hospital in Puente Genil

• Specialist of the Internal Medicine Unit. Costa del Sol Hospital

A member of:

• Spanish Society of Internal Medicine

• Spanish Society of Infectious Disease and Clinical Microbiology

• Spanish Society of Palliative Care

The Internal Medicine speciality is a branch of medicine that focuses on the diagnosis, treatment and prevention of diseases and conditions of adult patients. Internists of the Quirónsalud Marbella Hospital are experts in the comprehensive health care of their patients as they manage a broad range of medical conditions. The team of specialists of our Marbella hospital stands out for its comp rehensive approach and deep knowledge and skills relating to chronic disease. Their objective is to provide a high-quality medical service while guiding the patient and coordinating the actions against their diseases in close cooperation with the other specialists, if necessary, in order to obtain an adequate diagnosis and treatment. One fundamental part of the work of an internist is the management of chronical diseases such as diabetes, hypertension, heart and lung disease, amongst others.

These conditions often require follow-ups and adjustments to the treatment throughout time.

The Internal Medicine team does not only focus on the treatment of diseases, but also on their prevention. Internists work with their patients to identify the risk factors and promote healthy habits. 

 Posts and Affiliations

Clinical Director – Multidisciplinary Breast Unit Kliniken Essen-Mitte, Germany

Lead Breast Cancer Research Program, Kliniken Essen-Mitte

Executive Board Member of the AGO (Arbeitsgemeinschaft Gynäkologische Onkologie)

 Additional Roles

ESMO Faculty – Breast Cancer

Member of AWO Gyn – Commission for plastic and reconstructive surgery

Speaker of the AGIMed – Commission for Integrative Medicine of the AGO

Member of the Organ Commission Mamma of the AGO

Scientific Director of the WSG study group

Global PI, Head of clinical investigations and trials 27

IDMC´s, Steering Boards national and international

Scientific committee of international and national symposia in breast cancer and surgical oncology

 Organization Memberships

Memberships: European Society of Medical Oncology, American Society of Clinical Oncology,

European Academy of Senology, German Cancer Society, German Society of Gynecology and

Obstetrics, Working Group for Gynecological Oncology, German Society of Senology,

 Publications

Peer reviewed Publications: 322

First/Senior Author: 38

h-Index/i10-Index 66/232

Congress Abstracts/Proceedings: 443

Books/Book Chapter: 59

Invited oral Presentations/Lectures: 1032

DR. Arzu Musaeva

Education: Azerbaijan Medical University.

Specialization: therapist

Working hours and days: weekdays 10:00-15:00.

Training and membership:

16.02-31.03.2000 thematic development of the cycle “Current issues of infectious diseases”.

02.01-15.02.2001 thematic cycle “Clinical pharmacotherapy of internal diseases”.

improvement.

01-30.12.2005 thematic improvement in the course “Chronic renal failure”.

22.11-27.12.2005 "Applied Homotoxicology" (56 hours) prof. Safihan Gasanov.

26-30.01.2006 "Applied Homotoxicology" (36 hours) Dr. Klaus Kuestermann (Baden-Baden,

Germany).

12-24.11.2006 "Applied Homotoxicology" (48 hours) Doctor of Technical Sciences Elena Nekrasova

23-28.04.2007 "Homeoisopathy" Dr. Burkhard Flechsig.

28.05-02.06.2007 "Sanum Therapy" Dr. Anita Krake (Germany).

13.12. 2008. “Microbiological Therapy” Doctor of Medical Sciences Michael Schreiber (Germany).

14-18.03.2008 "Module B" Dr. Marion Krasnitzer-Geyer, Dr. med. Siddhartha Popat (Baden-

Baden, Germany).

20-22.06.2008. "Acupuncture and Homeosiniatry" Dr. med. Siddhartha Popat (Baden-Baden,

Germany).

27-29.11.2009. "Introduction to Homeosiniatry" Dr. med. Joachim Bandlow.

02/16/2010. "Homotoxicology" Dr. Alta Smith.

05-09.11.2010. Course "Applied Homotoxicology" (36 hours). Dr. med. Burkhard Flechsig, Dr. med.

Joachim Bandlow.

21-22. 01.2011. "Introduction to Isopathy and Sanum Therapy". Med. Thomas Rau.

04.04.2011. "Microbiological Therapy" Dr. Kerstin Rasch, Dr. Volker Rusch.

10.20.2013. "Traditional medicine with biological medicine in diseases of the endocrinological and lymphatic systems"

"Sharing Methods" by Dr. Jurgen Frost.

07.04-02.05.2014 "Azerbaijan State Medical Institute named after A.Aliyev"

refresher course.

11/12/2014. "Inflammation: A New Concept" by Dr. Alta Smith.

10-11.04.2015. "Diabetes, Stress and Associated Diseases" Dr. med. Siddhartha Popat

(Baden-Baden, Germany).

12-16.05.2015. "Neurology, autoimmune diseases" Dr. of Medical Sciences Thomas Rau (Switzerland).

05/28/2015. "Basics of acid-base balance" "Hormones and health" Dr. med. Burkhard

Flechsig (Germany).

10.21.2015. "Fundamentals of Oncology" by Dr. Gerhard Reiss (Germany).

12/21/2015. "Mesotherapy" Dr. Alta Smith (Germany).

01-03.04.2016. Dr. "Allergy, Inflammation, Stress". Bert Hannosset (Germany).

05/28-29/2016 “Aesthetic Medicine” Dr. Tatiana Rivkina (Italy).

06/13-14/2016 “Fibromyalgia, Gout, Psoriasis” Dr. med. Gerhard Reis (Germany).

04-08.10.2016. "Mucosa Syndrome" Dr. Arturo Obirne (Colombia).

21.10. 2016. "Microbiological Therapy" by Dr. Uwe Peters (Germany).

31.10-01.11.2016. "Thyroid depletion syndrome" Dr. Gerhard Reiss (Germany).

10-11.11.2017. "Microbiological therapy – the basis of regulation" Dr. Uwe Peters (Germany).

12.2017. "Neurotherapy and Homotoxicology" Dr. med. Siddhartha Popat (Baden-Baden,

Germany).

2017. "Metabolic Syndrome" Dr. med. Annette Jaensch.

2017. "Healthy Aging, Proven Remedies in Integrative Medicine", Dr. Ralf Ottmaier

(Switzerland).

14-20.05.2018. "From segment to barrier, nutrition and inflammation, vitamin C and diabetes", doctor.

honey. Arturo Obirne (Colombia).

15-17.11.2018 "Elimination Therapy Methods, Success in Old Age" Dr. Marion Krasnitzer-Geyer

(Baden-Baden, Germany).

04.2018. "Bioregulatory treatment of chronic infections" Dr.rer.nat. Petra Grüning.

21-23.09.2018. "Possibilities of treating degenerative diseases using systemic bioregulatory medicine"

Doctor med. Siddhartha Popat (Baden-Baden, Germany).

01/25/2019. "Basics of mistletoe therapy with Helixor and its application in practice" Doctor of Medical Sciences Christfried

Preussler (Germany).

05/11/2019 “Mesotherapy” Dr. Nicoletta Frasca

05/14/2019. "Sanum Therapy for Liver Diseases" by Dr. Dieter Sonntag

06.04.2019. "Isn't fatigue the call of the liver?" Dr. Petra Grüning.

14-19.10.2019. "Bioregulatory treatment of dermatological diseases". med. Arturo Obirne

(Colombia).

Based on the results of successful treatment of trophic ulcers of various origins with biological preparations

Received the Hans-Heinrich Reckeweg Prize for clinical cases.

Examinations and treatment performed:

• Bioregulatory therapy of all therapeutic diseases.

• Atherosclerosis, stenosis, occlusion of peripheral arteries.

• Varicose veins, thrombophlebitis, thrombosis, lymphostasis of peripheral veins.

• Peripheral nerve neuropathy.

• Diabetic paw, osteoarthropathy, osteomyelitis.

• Detoxification and bioregulation of blood glucose at the cellular level. Diabetes mellitus

treatment and prevention of delayed complications in the lower extremities.

• Gangrenous pyoderma.

• Treatment of trophic ulcers.

Dr. Şule Temiztürk is a rehabilitation specialist with over 15 years of experience. She focuses on neurological and orthopedic rehabilitation, musculoskeletal disorders, and rheumatological diseases. She is skilled in advanced procedures such as trigger point and intra-articular injections.

Dr. Temiztürk graduated from Ankara University Medical Faculty in 2005. She has worked at leading clinics and hospitals, including Şişli Eftal EAH and Antakya State Hospital. She is known for her strong contributions to patient recovery and rehabilitation in Turkey.

Chief physician, osteopathic therapist

Respiratory diseases (outpatient treatment of chronic obstructive pulmonary disease and bronchial asthma)

Allergic diseases

Gastrointestinal diseases

SPECIALITY:

Osteopathic therapist

Training and membership:

1991-1998 Azerbaijan Medical University, Faculty of Medicine

Internship in therapy in 1998-1999.

From 2004 to 2018 in the areas of application of Integrative Medicine - acupuncture, homeosiniatry,

biopuncture, neurotherapy, hirudotherapy, segmental therapy and other improvements

completed the courses.

2011-2012 – specialization “Bioresonance diagnostics and therapy” at MPEI.

In 2014-2018, he received a degree in osteopathy at the St. Petersburg Institute of Osteopathy.

2016 in Istanbul Çapa Hospital, 2018 in Ankara GATA Keçiören Hospital.

participated in experimental practice.

Participated in the 1st and 2nd Microbiome Congresses in Turkey in 2021-2022.

COVID19 Lung as speaker at Family Medicine Summit 2021 in Turkey

He spoke about the complications.

foreign specialists in Germany, various cities of Turkey and Azerbaijan

participated in many conferences